Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Fixed Capital/Sales

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.740.901.040.770.42

What is the latest Fixed Capital/Sales ratio of MEDICAMEN BIOTECH ?

The latest Fixed Capital/Sales ratio of MEDICAMEN BIOTECH is 0.74 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.74
Mar20230.90
Mar20221.04
Mar20210.77
Mar20200.42

How is Fixed Capital/Sales of MEDICAMEN BIOTECH Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.74
-17.78
Mar2023 0.9
-13.46
Mar2022 1.04
35.06
Mar2021 0.77
83.33
Mar2020 0.42 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare Fixed Capital/Sales ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹584.6 Cr 2.9% -12.1% -14.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,228.0 Cr -2.4% -7.2% 27.2% Stock Analytics
DIVIS LABORATORIES ₹148,023.0 Cr 0% -9.2% 61.5% Stock Analytics
CIPLA ₹119,474.0 Cr 6% -3.8% 10.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,599.0 Cr 1.7% -11.4% 2.2% Stock Analytics
ZYDUS LIFESCIENCES ₹97,604.7 Cr 5.2% -2.1% 26.1% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

2.9%

-12.1%

-14.5%

SENSEX

1.7%

-1.3%

7.7%


You may also like the below Video Courses